Journal of Pharmacy & Bioresources https://www.ajol.info/index.php/jpb <p>The <em>Journal of Pharmacy and Bioresources</em> (JPB) publishes scientific work in all areas of Pharmaceutical and life sciences, including (but not restricted to): medicinal plant research; herbal medicines and cosmetics; development of drugs and pharmaceuticals; quality assurance of drugs; safety and efficacy of drugs; pharmacy practice; veterinary pharmacy; bioresources development and conservation.</p> en-US <p>Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.</p> <p><strong>DECLARATION &amp; COPYRIGHT TRANSFER </strong></p> <p>I/We the undersigned author(s) of article entitled</p> <p>…………………………………………………………………………………………………………………</p> <p>…………………………………………………………………………………………………………………</p> <p>Declare as follows:</p> <ol> <li class="show">The manuscript submitted to Journal of Pharmacy &amp; Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.</li> <li class="show">The submitted manuscript is a joint decision of all the coauthors.</li> <li class="show">Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.</li> <li class="show">Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.</li> <li class="show">Authors do not have any conflict of interest (financial or otherwise) other than those declared.</li> <li class="show">If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.</li> </ol> <p>&nbsp;</p> <p>Name &amp; Signature of authors</p> <p>&nbsp; &nbsp; &nbsp; &nbsp;1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2.</p> <ol start="3"> <li class="show">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;4.</li> <li class="show">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;6.</li> <li class="show">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;8.</li> </ol> <p>&nbsp;</p> <p>Corresponding authors name address, affiliation and email:</p> ochekpen@unijos.edu.ng (Nelson A. Ochekpe) pharm_biores@yahoo.com (Press Editor: Taiwo E. Alemika) Tue, 21 Jan 2025 00:51:11 +0000 OJS 3.3.0.11 http://blogs.law.harvard.edu/tech/rss 60 Clinical antihypertensive efficacy and safety of <i>Moringa oleifera</i> Lam. (Moringaceae) leaf: a systematic review https://www.ajol.info/index.php/jpb/article/view/286885 <p>In low- and medium-income countries (LMICs) where access to medicines is challenging, hypertension prevalence is increasing, justifying the need to integrate traditional herbal medicines like <em>Moringa oleifera</em> into mainstream clinical practice. This review examines clinical studies in literature, starting from 2011, on the efficacy and safety of <em>Moringa oleifera</em> in hypertension treatment. Outcomes including effects on blood pressure, other cardiovascular risks, blood biochemistry, and adverse drug events were extracted from the articles. The quality of evidence was assessed with the risk of bias in non-randomised studies of interventions (ROBINS-1) tool. A total of 295 articles were identified, of which 16 were included for review. All but one were non-randomised studies. Regarding clinical efficacy, three articles, (n=131) showed that in normotensive patients, Moringa treatment has an acute BP-lowering effect but<br>repeated doses failed to demonstrate a BP-lowering effect (3 articles, n=82). In hypertensive populations (3 articles, n=112) Moringa supplementation had BP-lowering effects. In terms of clinical safety (2 articles, n=66) there are non-significant changes in blood biochemistry including alanine aminotransferase, creatinine and blood urea nitrogen in normotensive patients. Regarding treatment tolerability, there was no incidence of adverse events (2 articles, n=209) while others reported minor gastrointestinal upset and changes in appetite and sleep patterns (2 articles, n=103). Limited literature using non-randomised trial designs shows that <em>Moringa oleifera</em> leaf supplementation lowers blood pressure in persons with hypertension. <em>Moringa oleifera</em> leaf appears safe in normotensive patients.</p> Shalkur David, Maxwell Patrick Dapar, Nanloh Samuel Jimam Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286885 Tue, 21 Jan 2025 00:00:00 +0000 Quality assessment of five brands of ascorbic acid tablets marketed in Ogun state, Nigeria https://www.ajol.info/index.php/jpb/article/view/286886 <p>Ascorbic acid (vitamin C), a water-soluble vitamin, is an essential nutrient that plays a crucial role in the body's antioxidant defences. Since the body cannot synthesize it, ascorbic acid must be obtained through either dietary sources or supplements. The aim of this study was to assess the quality and physicochemical properties of five different brands of ascorbic acid commonly sold in several pharmacy outlets in Ogun State. The brands were analysed for their uniformity of weight, hardness, friability and disintegration time using official methods, quantitative analysis was done using dissolution test and high-performance liquid chromatography (HPLC). One out of the five brands (20%) passed the weight uniformity test ranging between 282.7 mg to 364.8 mg, four (80 %) of the five brands passed the hardness test and were within 1.5 and 6.0 KgF. All five brands passed the friability test, disintegration test and<br>dissolution test and were within 0.0172 - 0.5691%, 0.36 - 13.52 mins and 96 - 103% respectively. The amount of API in each brand ranging from 97.25% to 103.07% were within official specifications when assayed with HPLC. This study elucidates the need for regular post market surveillance of medications to ensure the safety of consumers.</p> David Gbenga Babalola, Olusegun Ayo Ade-Adekunle, Grace Omolola Ajasa, Precious Adebowale Dada Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286886 Tue, 21 Jan 2025 00:00:00 +0000 <i>In vitro</i> antioxidant and toxicity studies of <i>Sorindeia warneckei</i> Engl. (Anacardiaceae) stem methanol extract in laboratory animals https://www.ajol.info/index.php/jpb/article/view/286887 <p><em>Sorindeia warneckei</em> (SW) Engl. (Anacardiaceae) is a plant of medicinal and economic significance. Its edible fruits are used in medicinal baths and stems as traditional toothbrushes. This study evaluates the antioxidant activity and safety profile of SW stem extract. Antioxidant activity was assessed using the diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay. Acute and sub-acute toxicity tests were performed following the protocol described by the Organization for Economic Cooperation and Development (OECD). The methanol extract of SW was rich in phytochemicals, with total phenolic and flavonoid contents measured at 149.64 ± 0.50 mg/g rutin equivalent and 172.097 ± 0.28 mg/g gallic acid equivalent respectively. SW demonstrated dose-dependent antioxidant activity (IC<sub>50</sub><br>= 0.0246 mg/mL), comparable to ascorbic acid (IC<sub>50</sub> = 0.0195 mg/mL). Acute toxicity studies indicated a lethal dose (LD<sub>50</sub>) &gt; 2000 mg/mL. Haematological parameters were not adversely affected. However, certain biochemical markers exhibited significant alterations (p&lt;0.05) following 28 days of treatment. Histological analysis revealed structural changes in renal and hepatic tissues, including hepatocyte hyperpigmentation and disorganization of the renal parenchyma. The findings highlight SW stem methanol extract's antioxidant potential but suggest caution regarding prolonged use due to signs of toxicity.</p> Motunrayo V. Badejo, Olaoluwa O. Owokade, Joy Ebere, Isimot T. Arowona, Adediwura A. Fred-Jaiyesimi Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286887 Tue, 21 Jan 2025 00:00:00 +0000 Role of peroxisome proliferator-activated receptor (PPARα) in mediating renoprotective effects of fumarate https://www.ajol.info/index.php/jpb/article/view/286888 <p>Fumarate has been reported to exert renoprotective actions. This study investigated a potential association between renoprotective activities of fumarate and peroxisome proliferator activated receptor (PPARα). PPARα wild type (WT) and knockout (KO) mice were randomly grouped into three groups; control (mineral oil + distilled water, 10 mL/kg/day, p.o.), fumarate (1 mg/kg/day, p.o.) and fenofibrate (100 mg/kg/day, p.o.). Mice were treated for 10 days, after which they were anaesthetized with xylazine + ketamine, 100 mg/kg i.p. Cortical blood flow (CBF) was then measured using a laser Doppler. Biochemical analyses were carried out. Fumarate reduced CBF in PPARα WT mice compared to PPAR KO mice (280.3 ± 34.2 vs 449.8 ± 15 PU, p&lt;0.05). Nitric oxide production was significantly lower in fumarate-treated PPAR WT compared to PPAR KO mice (13.6 ± 1 vs 20.9 ± 3 μM/ng, p&lt;0.05). Catalase activity<br>was insignificantly different in PPAR WT and KO mice treated with fumarate (p&gt;0.05. Superoxide dismutase (SOD) activity was reduced by two-fold in PPAR WT mice compared to PPAR KO mice (p&lt;0.05). This study demonstrates that the effect of fumarate on CBF, nitric oxide and L-arginine metabolism may be partially modulated through the PPARα downstream signalling pathway.</p> Osaze Edosuyi, Myung Choi, Ighodaro Igbe, Adebayo Oyekan Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286888 Tue, 21 Jan 2025 00:00:00 +0000 Evaluation of the anthelmintic activity of ethanol leaf extract of <i>Dimocarpus longan</i> (Lour.) against <i>Taenia solium</i> https://www.ajol.info/index.php/jpb/article/view/286889 <p>Helminth infections affects nearly 1.5 billion people worldwide, particularly in tropical and subtropical regions, where poverty, inadequate housing, and poor sanitation, exacerbate their impact. These infections pose significant health and economic burdens, and the limited effectiveness of current anthelmintic drugs underscores the need for alternative treatments. <em>Dimocarpus longan</em>, traditionally used in various forms of medicine, is rich in bioactive compounds such as flavonoids, tannins, and saponins, which are known to exhibit antiparasitic properties. This study evaluated the anthelmintic potential of ethanol leaf extract of <em>D. longan</em> against <em>Taenia solium</em>, aiming to explore its use as a natural remedy for managing helminth infections. The extract, tested at concentrations of 25, 50, 100, and 200 mg/mL. alongside piperazine citrate (10 mg/mL) on adult <em>T. solium</em> worms obtained from freshly slaughtered pigs. The anthelmintic activity was measured by recording the time to paralysis and death of the worms. The extract showed significant concentration-dependent effects, with higher concentrations (100 &amp; 200 mg/mL) demonstrating efficacy comparable to piperazine citrate, exhibiting strong paralytic but weaker lethal effects on <em>T. solium</em>. The findings suggest that <em>D. longan</em> ethanol leaf extract has potent anthelmintic properties, making it a promising natural alternative for managing helminth infection.</p> Saidi Odoma, Felix Twinomugisha, Timothy Neeza, Funso Funso-Babarimisa Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286889 Tue, 21 Jan 2025 00:00:00 +0000 Phytochemical profiling, acute toxicity and haemostatic effects of methanol leaf extract of <i>Acanthus montanus</i> (Nees) T. Anderson (Acanthaceae) https://www.ajol.info/index.php/jpb/article/view/286890 <p><em>Acanthus montanus</em> leaf is used in African trado-medicine as a haemostatic agent, which could be ascribed to its bioactive principles. This study evaluated phytoconstituents and haemostatic potential of <em>Acanthus montanus</em> methanol leaf extract in albino Wistar rats, as well as acute toxicity in mice. Methanol extract of <em>Acanthus montanus</em> was analysed for phytochemicals by standard protocol and High Pressure Liquid Chromatography (HPLC). Acute toxicity was determined using established method, while the haemostatic parameters were determined using tail bleeding time and blood clotting time in albino Wistar rats at 200, 400 and 800 mg /kg b.w.; administered by gavage once daily for nine days. Alkaloids, tannins, saponins, flavonoids, glycosides and steroids were inferred from the<br>phytochemical screening. Nineteen phytoconstituents were identified and quantified via HPLC, with catechin and rutin showing documented evidence of haemostatic effect. <em>Acanthus montanus</em> was considered safe since no death or change in behaviour was observed at maximum dose of 5000 mg/kg b w. A significantly dose dependent decrease (P&lt;0.001) in clotting and bleeding time was noted across the groups. The 800 mg/kg treated group was comparable to vitamin K (10mg/kg b w) treated group. This reaffirms the traditional use of <em>Acanthus montanus</em> leaf as haemostatic agent.</p> Chinyelu Clementina Osigwe, Chijindu Anderline Nwaorusha, Emmanuel Eimiomodebheki Odion Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286890 Tue, 21 Jan 2025 00:00:00 +0000 <i>In silico</i> evaluation of verbenone and selected solubilizing compounds against diabetes-related proteins https://www.ajol.info/index.php/jpb/article/view/286891 <p>Verbenone is a colourless, minty liquid that is soluble in non-polar solvents with <em>in vitro</em> and <em>in vivo</em> antidiabetic activities. This study evaluates verbenone and selected solubilizing compounds <em>in silico</em> against diabetes related proteins which included glucokinase (1V4S), human pancreatic α-amylase (1B2Y), and sucrase-isomaltase (3AXH). The structures of verbenone, acarbose, and five identified solubilizing compounds were downloaded in SDF format from the PubChem database. The binding energies were computed using Autodock Vina software while physicochemical properties and ADME parameters were predicted using SwissADME server. In glucokinase and human pancreatic α-amylase, the binding affinity (Kcal/mol) of verbenone (-5.4, -5.9) was superior to lysine (-4.5, -<br>4.7) and eudragit (-4.5, -3.6), while in sucrase-isomaltase, the binding affinity (Kcal/mol) of verbenone (-6.1) was superior to lysine (-5.2), cyclodextrin (-4.8) and eudragit (-4.0) respectively. Only cyclodextrin violated the Lipinski rule of five. More so, cyclodextrin, lysine and eudragit are very soluble, with low lipophilicity compared with verbenone. Lysine and eudragit possess high gastrointestinal absorption and are not suitable P-gp substrate, while eudragit can effectively cross blood brain barrier. The study identified cyclodextrin, lysine and eudragit as potent candidates to improve the bioactivity of verbenone, as alternate means to improve the antidiabetic activity of verbenone.</p> Oluremi A. Saliu, Blessing Edogbo, Suwaiba Nasir, Shehu Usman Adamu, Salima Adamu Sada, Adamu Abdullahi, Ayodeji O. Idowu, Moses Dele Adams, Habibu Tijjani Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286891 Tue, 21 Jan 2025 00:00:00 +0000 Anxiolytic and antidepressant effects of ethanol extract of <i>Ocimum</i> gratissimum L. (Lamiaceae) https://www.ajol.info/index.php/jpb/article/view/286893 <p><em>Ocimum gratissimum</em>, commonly known as clove basil or aromatic basil, has been traditionally utilized for its potential medicinal benefits, including anxiolytic and antidepressant effects. This study aimed to evaluate the anxiolytic and antidepressant properties of methanol extract of <em>Ocimum gratissimum</em> at doses of 100, 200, and 400 mg/kg po. Using a Chronic Unpredictable Mild Stress (CUMS) model, mice were divided into 5 groups (n = 6/group). The animals were weighed during the CUMS exposure to monitor stress-induced changes. The negative control group received normal saline, while the positive control group was administered Imipramine (30 mg/kg po) and three treatment groups received the extract. Behavioural responses were assessed using the elevated plus maze, open field test, and forced swim test, with body weight changes monitored as a stress indicator. Results showed that animals treated with <em>O.</em> <em>gratissimum</em> extract at all doses tested showed significant reductions in anxiety-like and depressive-like behaviours<br>compared to the negative control. Weight loss, a common indicator of stress, was significantly mitigated in the <em>O. </em><em>gratissimum</em> treated groups. These findings suggest that <em>O. gratissimum</em> possesses substantial anxiolytic and antidepressant effects, with higher doses showing greater efficacy and improved weight maintenance, supporting its traditional use in managing anxiety and depression.</p> Lydia D. Ior, Florence F. Rwang, Abigail A. Daniel, Samuel O. Ede, Tongret Datok Copyright (c) 2025 https://www.ajol.info/index.php/jpb/article/view/286893 Tue, 21 Jan 2025 00:00:00 +0000